PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 56 filers reported holding PROQR THRAPEUTICS N V in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $20,000 | – | 22,600 | +56400.0% | 0.00% | – |
| Q4 2021 | $0 | – | 40 | +73.9% | 0.00% | – |
| Q3 2021 | $0 | – | 23 | -34.3% | 0.00% | – |
| Q2 2021 | $0 | – | 35 | 0.0% | 0.00% | – |
| Q1 2021 | $0 | -100.0% | 35 | -98.9% | 0.00% | – |
| Q4 2020 | $13,000 | -69.8% | 3,188 | -64.5% | 0.00% | – |
| Q3 2020 | $43,000 | -32.8% | 8,988 | -14.3% | 0.00% | – |
| Q2 2020 | $64,000 | +255.6% | 10,488 | +212.8% | 0.00% | – |
| Q1 2020 | $18,000 | +350.0% | 3,353 | +858.0% | 0.00% | – |
| Q4 2019 | $4,000 | -66.7% | 350 | -84.7% | 0.00% | – |
| Q3 2019 | $12,000 | -33.3% | 2,287 | +9.8% | 0.00% | – |
| Q2 2019 | $18,000 | -92.6% | 2,083 | -88.1% | 0.00% | – |
| Q1 2019 | $243,000 | +376.5% | 17,453 | +442.7% | 0.00% | – |
| Q4 2018 | $51,000 | – | 3,216 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Privium Fund Management B.V. | 5,344,446 | $18,010,783 | 6.83% |
| M28 Capital Management LP | 1,910,600 | $7,069,220 | 6.74% |
| Opaleye Management Inc. | 1,460,000 | $5,402,000 | 1.88% |
| Ikarian Capital, LLC | 422,625 | $1,563,713 | 0.38% |
| Monaco Asset Management SAM | 165,000 | $610,500 | 0.18% |
| AWM Investment Company, Inc. | 166,667 | $616,668 | 0.09% |
| FRANKLIN STREET ADVISORS INC /NC | 150,000 | $555 | 0.05% |
| Atom Investors LP | 18,522 | $68,531 | 0.03% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3,625,467 | $13,414,228 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 21,514 | $80 | 0.01% |